1. Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis. Issue 2 (10th January 2019) Authors: Battat, Robert; Dulai, Parambir S; Vande Casteele, Niels; Evans, Elisabeth; Hester, Kelly D; Webster, Edvelyn; Jain, Anjali; Proudfoot, James A; Mairalles, Ara; Neill, Jennifer; Singh, Siddharth; Chang, John T; Rivera-Nieves, Jesus; Sandborn, William J; Boland, Brigid S Journal: Inflammatory bowel diseases Issue: Volume 25:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative Colitis. Issue 2 (5th October 2018) Authors: Battat, Robert; Dulai, Parambir S; Vande Casteele, Niels; Evans, Elisabeth; Hester, Kelly D; Webster, Edvelyn; Jain, Anjali; Proudfoot, James A; Mairalles, Ara; Neill, Jennifer; Singh, Siddharth; Chang, John T; Rivera-Nieves, Jesus; Sandborn, William J; Boland, Brigid S Journal: Inflammatory bowel diseases Issue: Volume 25:Issue 2(2019) Page Start: 410 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗